Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    Single-center study outlines stroke risk, DOAC type in nonvalvular AFib patients

    May 6, 2019

    PHILADELPHIA –Rivaroxaban was more often than other DOACs associated with events in nonvalvular atrial fibrillation patients, based on a small study from a tertiary care center in Australia.

  • 1
    News

    Long-term antibiotic use may heighten stroke, CHD risk

    April 28, 2019

    Among middle-aged and older women, 2 or more months’ exposure to antibiotics is associated with an increased likelihood of cardiovascular disease.

  • 1
    News

    Epinephrine linked with more refractory cardiogenic shock after acute MI

    April 18, 2019

    Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in acute myocardial infarction (AMI)?

  • 1
    News

    Poor response to statins hikes risk of cardiovascular events

    April 17, 2019

    Patients with better outcomes were more likely to have initiated therapy with a more potent drug.

  • 1
    News

    Statin exposure associated with idiopathic inflammatory myositis

    April 15, 2019

    What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?

  • 1
    News

    PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan

    April 14, 2019

    NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore

  • 1
    Video

    Highlights from the ‘Updates in ACS’ session (VIDEO) 

    April 12, 2019

    HM19 attendees discuss the key lessons from the Updates in Acute Coronary Syndrome session.

  • 1
    News

    Clinicians, CMS confer over heart failure–readmission penalty

    April 10, 2019

    Evidence showed the CMS hospital penalty for excess heart failure readmissions has had unintended adverse consequences and needs fixing.

  • 1
    News

    One-dose-fits-all aspirin administration strategy may not be advisable

    April 5, 2019

    Are the same doses of aspirin equally effective in preventing cardiovascular (CV) events and long-term colorectal risk reduction in patients of various body sizes?

  • 1
    News

    30-day readmissions after STEMI with cardiogenic shock 13%

    April 2, 2019

    WASHINGTON – Risk factors for 30-day readmission included female sex, older age, and comorbidities.

Previous1 … 48 49 50 51 52 … 80Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences